Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatitis B virus (HBV) viremia despite tenofovir disoproxil fumarate-containing antiretroviral therapy in persons with HBV/HIV coinfection.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Dec 2024

Ryan Patrick, Odegard Elizabeth, Meeds Heidi, Lartey Margaret, Ganu Vincent J, Tachi Kenneth, Yang Hongmei, Ojewale Oluwayemisi, Boamah Isaac, Obo-Akwa Adjoa, Antwi Kenneth, Anderson Peter L, Blackard Jason T, Kwara Awewura

Abstract excerpt

BACKGROUND: The goal of treatment of hepatitis B virus (HBV) and human immunodeficiency virus (HIV) coinfection is suppression of both viruses; yet incomplete HBV suppression on tenofovir (TFV) disoproxil fumarate (TDF)-based antiretroviral therapy (ART) is common. This study investigated TFV resistance-associated mutations (RAMs) in individuals with HBV/HIV coinfection with viremia on TDF/lamivudine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Coinfection

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B

Share to Lamivudine

Share to Tenofovir

Share to Viral Load

Share to Viremia

Source

Identifiers

PMID: 39413542
DOI: 10.1016/j.jcv.2024.105733

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatitis B virus (HBV) viremia despite tenofovir disoproxil fumarate-containing antiretroviral therapy in persons with HBV/HIV coinfection.PMID 39413542Read ↗

Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adultsSemantic proximity Read ↗

Evidence of Tenofovir Resistance in Chronic Hepatitis B Virus (HBV) Infection: An Observational Case Series of South African AdultsSemantic proximity Read ↗

HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons.Semantic proximity Read ↗

Hepatitis B virus resistance to tenofovir: fact or fiction? A synthesis of the evidence to dateSemantic proximity Read ↗

Hepatitis B virus resistance to tenofovir: fact or fiction? A systematic literature review and structural analysis of drug resistance mechanismsSemantic proximity Read ↗

Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations.Semantic proximity Read ↗

HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients.Semantic proximity Read ↗

Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus.Semantic proximity Read ↗

Effects of long-term tenofovir-based combination antiretroviral therapy in HIV-hepatitis B virus coinfection on persistent hepatitis B virus viremia and the role of hepatitis B virus quasispecies diversity.Semantic proximity Read ↗

Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response.Semantic proximity Read ↗

Novel hepatitis B virus reverse transcriptase mutations in patients with sustained viremia despite long-term tenofovir treatment.Semantic proximity Read ↗

Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.